Effects of LM1215 on and .

Won-Young Bae, Young Jin Lee, Subin Jo, So Lim Shin, Tae-Rahk Kim, Minn Sohn, Hyun-Joo Seol
Author Information
  1. Won-Young Bae: Microbiome R&D Center, Lactomason, Seoul, Korea. ORCID
  2. Young Jin Lee: Microbiome R&D Center, Lactomason, Seoul, Korea. ORCID
  3. Subin Jo: Center for Research and Development, Lactomason, Jinju, Korea. ORCID
  4. So Lim Shin: Microbiome R&D Center, Lactomason, Seoul, Korea. ORCID
  5. Tae-Rahk Kim: Microbiome R&D Center, Lactomason, Seoul, Korea. ORCID
  6. Minn Sohn: Microbiome R&D Center, Lactomason, Seoul, Korea. ORCID
  7. Hyun-Joo Seol: Department of Obstetrics and Gynecology, Kyung Hee University Hospital at Gangdong, Seoul, Korea. seolhj@khu.ac.kr. ORCID

Abstract

PURPOSE: The aim of this study was to identify novel vaginal probiotics with the potential to prevent vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV).
MATERIALS AND METHODS: Eighteen strains of were isolated from healthy Korean women, and their antimicrobial effects against and were assessed. Three strains ( LM1203, LM1209, and LM1215) were selected for further investigation, focusing on their growth inhibition, biofilm regulation, and cellular mechanisms against these vaginal pathogens. Additionally, electron microscopy revealed damage to induced by LM1215, and genomic analysis was conducted on this strain.
RESULTS: LM1203, LM1209, and LM1215 showed approximately 1 and 2 Log CFU/mL growth reduction in and , respectively. These strains effectively inhibited biofilm formation and eliminated the mature biofilms formed by . Furthermore, LM1215 decreased tricarboxylic acid cycle activity by 51.75 (<0.001) and respiratory metabolic activity by 52.88% (<0.001) in . induced cellular membrane damage, inhibition of protein synthesis, and cell wall collapse in . Genomic analysis confirmed LM1215 as a safe strain for vaginal probiotics.
CONCLUSION: The LM1215 is considered a safe probiotic agent suitable for the prevention of VVC and BV.

Keywords

References

  1. Probiotics Antimicrob Proteins. 2023 Oct;15(5):1436-1446 [PMID: 36198994]
  2. Bioinformatics. 2012 Feb 15;28(4):464-9 [PMID: 22199388]
  3. Molecules. 2020 Nov 26;25(23): [PMID: 33255863]
  4. N Engl J Med. 2020 May 14;382(20):1906-1915 [PMID: 32402161]
  5. Arch Gynecol Obstet. 2022 Jul;306(1):101-108 [PMID: 35246717]
  6. Mol Plant. 2020 Aug 3;13(8):1194-1202 [PMID: 32585190]
  7. Arch Microbiol. 2021 Sep;203(7):3793-3802 [PMID: 34120200]
  8. Cochrane Database Syst Rev. 2022 Jan 10;1:CD009151 [PMID: 35005777]
  9. Antibiotics (Basel). 2022 Oct 25;11(11): [PMID: 36358129]
  10. Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903 [PMID: 24777092]
  11. BJOG. 2020 Jan;127(2):287-299 [PMID: 31299136]
  12. J Cosmet Dermatol. 2023 Nov;22(11):3125-3134 [PMID: 37177837]
  13. Sci Rep. 2023 Jul 27;13(1):12212 [PMID: 37500806]
  14. BJOG. 2009 Oct;116(11):1499-505 [PMID: 19583713]
  15. Foods. 2022 Apr 28;11(9): [PMID: 35564005]
  16. Microorganisms. 2021 Feb 26;9(3): [PMID: 33652865]
  17. Reprod Health. 2022 Jun 13;19(1):137 [PMID: 35698149]
  18. Nucleic Acids Res. 2018 Jul 2;46(W1):W246-W251 [PMID: 29790974]
  19. Bioinformatics. 2009 Jan 1;25(1):119-20 [PMID: 18990721]
  20. Infect Drug Resist. 2022 Aug 02;15:4155-4168 [PMID: 35942309]
  21. Syst Biol. 2012 Dec 1;61(6):1061-7 [PMID: 22780991]
  22. Microorganisms. 2021 Dec 13;9(12): [PMID: 34946178]
  23. Sci Rep. 2021 Jan 28;11(1):2592 [PMID: 33510271]
  24. Food Microbiol. 2021 Feb;93:103611 [PMID: 32912582]
  25. Int J Mol Sci. 2021 Nov 08;22(21): [PMID: 34769500]
  26. Nucleic Acids Res. 2022 Jan 7;50(D1):D912-D917 [PMID: 34850947]
  27. Microorganisms. 2021 Aug 09;9(8): [PMID: 34442768]
  28. Nucleic Acids Res. 2022 Jul 5;50(W1):W768-W773 [PMID: 35524563]
  29. Microorganisms. 2022 Apr 15;10(4): [PMID: 35456875]
  30. Front Microbiol. 2022 Feb 15;13:774184 [PMID: 35242114]
  31. Genome Biol. 2019 Nov 14;20(1):238 [PMID: 31727128]
  32. Food Microbiol. 2022 Jun;104:103999 [PMID: 35287818]
  33. Antonie Van Leeuwenhoek. 2017 Oct;110(10):1281-1286 [PMID: 28204908]
  34. Sci Rep. 2021 Sep 21;11(1):18774 [PMID: 34548600]
  35. Nucleic Acids Res. 2023 Jul 5;51(W1):W46-W50 [PMID: 37140036]
  36. Genome Res. 2004 Jul;14(7):1394-403 [PMID: 15231754]
  37. PLoS One. 2013 Oct 28;8(10):e77302 [PMID: 24204795]
  38. BMC Womens Health. 2023 Mar 18;23(1):112 [PMID: 36934289]
  39. PLoS One. 2012;7(4):e34540 [PMID: 22509319]
  40. Curr Microbiol. 2021 Aug;78(8):2839-2849 [PMID: 34076710]
  41. mSystems. 2021 Aug 31;6(4):e0062221 [PMID: 34374560]
  42. Compr Rev Food Sci Food Saf. 2022 Jan;21(1):604-641 [PMID: 34907656]
  43. J Appl Microbiol. 2021 Feb;130(2):394-404 [PMID: 32734653]

Grants

  1. 121026-3/Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries

MeSH Term

Candida albicans
Gardnerella vaginalis
Humans
Female
Biofilms
Probiotics
Candidiasis, Vulvovaginal
Lactobacillus plantarum
Vaginosis, Bacterial
Vagina

Word Cloud

Created with Highcharts 10.0.0LM1215vaginalprobioticsstrainsvulvovaginalcandidiasisVVCbacterialvaginosisBVLM1203LM1209growthinhibitionbiofilmcellulardamageinducedanalysisstrainactivity<0001safePURPOSE:aimstudyidentifynovelpotentialpreventMATERIALSANDMETHODS:EighteenisolatedhealthyKoreanwomenantimicrobialeffectsassessedThreeselectedinvestigationfocusingregulationmechanismspathogensAdditionallyelectronmicroscopyrevealedgenomicconductedRESULTS:showedapproximately12LogCFU/mLreductionrespectivelyeffectivelyinhibitedformationeliminatedmaturebiofilmsformedFurthermoredecreasedtricarboxylicacidcycle5175respiratorymetabolic5288%membraneproteinsynthesiscellwallcollapseGenomicconfirmedCONCLUSION:consideredprobioticagentsuitablepreventionEffectsLactiplantibacillusplantarummicrobialsensitivitytest

Similar Articles

Cited By